期刊文献+

腹腔镜十二指肠空肠旁路术治疗非肥胖2型糖尿病初步探讨 被引量:7

下载PDF
导出
摘要 2型糖尿病(T2DM)作为一种常见的难以根治的慢性病,传统药物和胰岛素治疗的目标只是维持正常血糖水平,患者需要终生用药。糖尿病外科手术的目标是让T2DM患者在不再用药和不再饮食控制的情况下,术后血糖得以终生维持在正常水平。从上世纪90年代初开始,
出处 《温州医学院学报》 CAS 2010年第2期171-172,共2页 Journal of Wenzhou Medical College
  • 相关文献

参考文献11

  • 1Pories WJ.Diabetes:the evolution of a new paradigm[J].Ann Surg,2004,239(1):12-13.
  • 2Schauer PR,Burguera B,Ikramuddin S,et al.Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus[J].Ann Surg,2003,238(4):467-484,discussion 84-85.
  • 3Rubino F,Marescaux J.Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes:a new perspective for an old disease[J].Ann Surg,2004,239(1):1-11.
  • 4Rubino F,Forgione A,Cummings DE,et al.The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes[J].Ann Surg,2006,244(5):741-749.
  • 5Rubino F.Is type 2 diabetes an operable intestinal disease A provocative yet reasonable hypothesis[J].Diabetes Care,2008,31(Suppl 2):S290-296.
  • 6Sugerman HJ,Wolfe LG,Sica DA,et al.Diabetes and hypertension in severe obesity and efects of gastric bypass-in-duced weight loss[J].Ann Surg,2003,237(6):751-756.
  • 7Flatt PR.Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP):evidence and clinical opportunity for development of new obesity-diabetes drugs[J].Diab Vasc Dis Res,2007,4(2):151-153.
  • 8Cohen RV,Schiavon CA,Pinheiro JS,et al.Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2:a report of 2 cases[J].Surg Obes Relat Dis,2007,3(2):195-197.
  • 9Ramos AC,Galvao NMP,de Souza YM,et al.Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI)[J].Obes Surg,2009,19:307-312.
  • 10Geloneze B,Geloneze SR,Fiori C,et al.Surgery for nonobese type 2 diabetic patients:an interventional study with duodenal-jejunal exclusion[J].Obes Surg,2009,19:1077-1083.

二级参考文献30

  • 1Pories WJ. Diabetes: the evolution of a new paradigm[J].Ann Surg, 2004, 239(1):12-13.
  • 2Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus[J]. Ann Surg, 2003, 238(4):467-484,discussion 84-85.
  • 3Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes--a systematic review[J]. Diabetes Metab Res Rev,2004,20(6):438-445.
  • 4Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution[J].J Clin Endocrinol Metab,2004,89(6):2608-2615.
  • 5Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and efects of gastric bypass-induced weight loss[J]. Ann Surg,2003,237(6):751-756.
  • 6Flatt PR. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs? [J]. Diab Vasc Dis Res, 2007, 4(2): 151-153.
  • 7Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis[J].Diabetes Care, 2008, 31(Suppl 2): S290-296.
  • 8Pender C, Goldfine ID, Tanner C J, et al. Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia[J]. Int J Obes Relat Metab Disord,2004, 28(3):363-369.
  • 9Houmard JA, Tanner C J, Yu C, et al. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl- CoAs in morbidly obese subjects[J]. Diabetes,2002, 51 ( 10):2959-2963.
  • 10Zhou H, Yamada Y, Tsukiyama K, et al. Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action[J]. Biochem Biophys Res Commun, 2005,335(3):937-942.

共引文献12

同被引文献72

  • 1洪友兰,汪凤梅.胃切除术应用液囊空肠导管的护理[J].浙江临床医学,2006,8(5):559-559. 被引量:9
  • 2Rubino F.Is Type 2 Diabetes an Operable Intestinal Disease? A Provocative Yet Reasonable Hypothesis[J].Diabetes Care,2008,31(Suppl 2):290-296.
  • 3Sugerman H J,Wolfe L G,Sica D A,et al.Diabetes and Hypertension in Severe Obesity and Efects of Gastric Bypass-Induced Weight Loss[J].Ann Surg,2003,237(6):751-756.
  • 4Flatt P R.Effective Surgical Treatment of Obesity May Be Mediated by Ablation of the Lipogenic Gut Hormone Gastric Inhibitory Polypeptide (GIP):Evidence and Clinical Opportunity for Development of New Obesity-Diabetes Drugs?[J].Diab Vasc Dis Res,2007,4(2):151-153.
  • 5Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus [ J ]. Ann Surg, 1995,222 ( 3 ) : 339- 350; discussion 350-332.
  • 6Rubino F, Mareseaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes : a new perspective for an old disease [ J ]. Ann Surg, 2004,239 ( 1 ) : 1-11.
  • 7Cohen RV, Schiavon CA, Pinheiro JS, et al. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m^2. : a report of 2 eases [ J ]. Surg Obes Relat Dis, 2007,3(2) :195-197.
  • 8Ramos AC, Galvao Neto MP, de Souza YM, et al. Laparoscopic dundenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI) [ J 1. Obes Surg, 2009,19(3) :307-312.
  • 9Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients:an interventional study with duodenal-jejunal exelusinn[ ] ]. Obes Surg, 2009,19 (8) : 1077-1083.
  • 10Ferzli GS, Dominique E, Ciaglia M, et al. Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis[ J]. World J Surg, 2009,33 ( 5 ) :972-979.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部